Case | Age | FIGO stage | Pathologic diagnosis | CTx regimen | Follow-up period (mo) | Time of recurrence after CTx (mo) | Response group | Status of survival |
---|---|---|---|---|---|---|---|---|
1 | 42 | IIIc | HGSC | Carbo-Taxol | 15 | 4 | CR | No |
2 | 63 | IV | HGSC | Carbo-Taxol | 29 | 8 | CR | No |
3 | 79 | IIIc | HGSC | Carbo-Taxol | 17 | 4 | CR | N/A |
4 | 66 | IIIc | HGSC | Carbo-Taxol | 29 | Progression during CTx | CR | N/A |
5 | 62 | IV | HGSC | Carbo-Taxol | 10 | 1 | CR | No |
6 | 73 | IV | HGSC | Carbo-Taxol | 30 | Relapse within CTx | CR | Yes |
7 | 64 | IIIc | HGSC | Carbo-Taxol | 35 | No relapse | CS | Yes |
8 | 55 | IIIc | HGSC | Carbo-Taxol | 51 | No relapse | CS | Yes |
9 | 62 | IIIc | HGSC | Carbo-Taxol | 64 | No relapse | CS | Yes |
10 | 69 | IIa | HGSC | Carbo-Taxol | 39 | 32 | CS | Yes |
11 | 50 | IIIc | HGSC | Carbo-Taxol | 24 | No relapse | CS | Yes |
12 | 49 | IV | HGSC | Carbo-Taxol | 75 | 19 | CS | Yes |